Jpmorgan Chase & Co »

Bright Minds Biosciences shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $331k 4.8k 69.18
2026-03-31 $265k 3.9k 68.45
2025-09-30 $319k 5.3k 60.66
2025-03-31 $2.4k 300 7.98

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Bright Minds Biosciences

Jupiter Topco
Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Vestal Point Capital
Braidwell
Driehaus Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Point72 Asset Management
Deerfield Management Company
RA Capital Management
Parkman Healthcare Partners
MPM Oncology Impact Management

View all funds holding Bright Minds Biosciences